Kinstellar advises Arkema on the acquisition of Den Braven
August 2016 – Kinstellar advised Arkema SA, a global innovative chemical company, on the acquisition of the Dutch sealant-and-adhesives maker Den Braven from Egeria, a Benelux buyout house, in a deal valued at EUR 485 million. The transaction was managed in over 25 jurisdictions by Loyens & Loeff, with Kinstellar's team, led by Nina Tsifudina, providing all local law advice in each of Bulgaria, Romania, Turkey and Ukraine.
Arkema is a global chemical major focusing on specialty chemicals and performance materials. It has operations in over 40 countries. The acquisition of Den Braven is a step towards expanding the High Performance Materials segment which should account for 50% of the Group’s sales by 2020.
Den Braven is a leading player in high performance sealants in Europe. It has 8 production sites around the world, about 1,000 employees, and over €350 million sales for 2016.